Clinical trials recruiting for Respiratory Tract Neoplasms
4
Recruiting trials
0
US states with sites
2
Countries
25%
Accept healthy volunteers
Phase breakdown
Phase 2 3Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Adebrelimab | 1 |
| Carboplatin | 1 |
| Carboplatin/Cisplatin | 1 |
| Cemiplimab | 1 |
| Etoposide | 1 |
| Paclitaxel | 1 |
| Tarlatamab | 1 |
Self-screener
Recruiting trials
- A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
- Early Intervention Strategies for Lung Cancer
- PALACE: Cemiplimab Trial According to ctDNA Levels
- Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
Related conditions
Trials recruiting for Respiratory Tract Neoplasms often also study these conditions. Each links to its own recruiting-trial list.
Thoracic Neoplasms 8Lung cancer 2180Lung Diseases 10Respiratory Tract Diseases 4Neoplasms by Site 11Lung Neoplasms 33Stage IV Non-small Cell Lung Cancer 7Stage III Non-small Cell Lung Cancer 6Small Cell Lung Carcinoma 20Non Small Cell Lung Cancer Metastatic 16
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Respiratory Tract Neoplasms trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.